World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
42677
World Ranking
6523
National Ranking
372

Overview

Wolfgang Kern is affiliated with the Munich Leukemia Laboratory in Germany. Their research focuses primarily on the fields of Medicine, with specialized subfields including Hematology, Genetics, Molecular Biology, Cancer Research, and Immunology.

Their work encompasses significant topics in hematologic malignancies and cancer diagnostics. The main research areas include:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia Research
  • Cancer Genomics and Diagnostics
  • Chronic Lymphocytic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Lymphoma Diagnosis and Treatment

Kern has contributed to multiple recent publications, including:

  • 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party (2021, Blood)
  • Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes (2021, Journal of Clinical Oncology)
  • Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms (2020, Blood)
  • Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia (2021, Cancer Discovery)
  • Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes (2023, Journal of Clinical Oncology)

The scientist frequently publishes in several journals, notably:

  • Blood (88 publications)
  • Cytometry Part B Clinical Cytometry (25 publications)
  • Leukemia (23 publications)
  • HemaSphere (13 publications)
  • Blood Advances (7 publications)

Wolfgang Kern collaborates often with a core group of coauthors, including:

  • Torsten Haferlach
  • Manja Meggendorfer
  • Claudia Haferlach
  • Constance Baer
  • Stephan Hütter

Best Publications

  • Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

    T Haferlach;Y Nagata;V Grossmann;Y Okuno

  • Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

    Susanne Schnittger;Claudia Schoch;Martin Dugas;Wolfgang Kern

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

    Gerrit J. Schuurhuis;Michael Heuser;Sylvie Freeman;Marie Christine Béne

  • Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

    Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci

  • Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

    Yasunobu Nagata;Vera Grossmann;Yusuke Okuno;Ulrike Bacher

  • Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia

    C H Pui;M V Relling;J T Sandlund;J R Downing

  • KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

    Susanne Schnittger;Tobias M. Kohl;Torsten Haferlach;Wolfgang Kern

  • Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

    Ulrike Bacher;Claudia Haferlach;Wolfgang Kern;Torsten Haferlach

  • 2021 Update Measurable Residual Disease in Acute Myeloid Leukemia: European LeukemiaNet Working Party Consensus Document.

    Michael Heuser;Sylvie D Freeman;Gert J Ossenkoppele;Francesco Buccisano

  • Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV H status and immunophenotyping

    C Haferlach;F Dicker;S Schnittger;W Kern

  • AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

    Claudia Schoch;Susanne Schnittger;Mirjam Klaus;Wolfgang Kern

  • Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML

    Susanne Schnittger;Wolfgang Kern;Claudia Tschulik;Tamara Weiss

  • Dynamics of clonal evolution in myelodysplastic syndromes

    Hideki Makishima;Hideki Makishima;Tetsuichi Yoshizato;Kenichi Yoshida;Mikkael Sekeres

  • Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

    Alexander Kohlmann;Vera Grossmann;Hans-Ulrich Klein;Sonja Schindela

  • Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

    Thomas Büchner;Wolfgang E. Berdel;Claudia Haferlach;Torsten Haferlach

  • Implications of NRAS mutations in AML: a study of 2502 patients.

    Ulrike Bacher;Torsten Haferlach;Claudia Schoch;Wolfgang Kern

  • Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

    Wolfgang Kern;Torsten Haferlach;Claudia Schoch;Helmut Löffler

  • IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

    Susanne Schnittger;Claudia Haferlach;Madlen Ulke;Tamara Alpermann

  • Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.

    J Casper;W Knauf;I Blau;T Ruutu

Frequent Co-Authors

Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Claudia Haferlach
Claudia Haferlach Ludwig-Maximilians-Universität München
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Claudia Schoch
Claudia Schoch MLL Munich Leukemia Laboratory
Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Martin Dugas
Martin Dugas Heidelberg University
Seishi Ogawa
Seishi Ogawa Kyoto University
Achim Heinecke
Achim Heinecke University of Münster
Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Hubert Serve
Hubert Serve Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA opens up a range of related online degrees and flexible career options. For those interested in entering the healthcare sector quickly, programs like online medical billing and coding with financial aid are popular. These courses provide specialized skills and allow you to start a healthcare career without lengthy traditional schooling.

If nursing is your goal, innovative options such as the lpn program no entrance exam remove common barriers to enrollment, helping you launch your journey faster. For those interested in leadership and administration, earning a health administration degree online can lead to rewarding roles managing healthcare facilities or departments.

Additionally, nurses with an associate degree can advance their qualifications through adn to fnp bridge programs that streamline the path to becoming a Family Nurse Practitioner. These alternatives offer practical routes into healthcare, supporting diverse interests and career ambitions.

Best Scientists Citing Wolfgang Kern

Trending Scientists

Recently Published Articles